Dr. Allison P. Wall, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
1340 Broad Ave, Suite 270
Gulfport, MS 39501
Who else practices at this address →
Harrison County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Alabama School of Medicine (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,092
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: University of Alabama School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
MS license 20162
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hospital at Gulfport Gulfport, MS
- Singing River Gulfport Gulfport, MS
- Singing River Health System Pascagoula, MS
- Memorial Hospital Biloxi Biloxi, MS
Medical groups
- Memorial Hospital at Gulfport (474 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,092
- Services billed
- 5,057
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 3,387 | 974 |
| Established patient office or other outpatient visit, 40-54 minutes | 1,109 | 444 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 252 | 106 |
| New patient office or other outpatient visit, 60-74 minutes | 106 | 106 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 73 | 64 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 73 | 46 |
| New patient office or other outpatient visit, 45-59 minutes | 27 | 27 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | 20 |
| Transitional care management services for problem of high complexity | 22 | 20 |
| Established patient office or other outpatient visit, 20-29 minutes | 15 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ondansetron Hcl Other prescribers in Gulfport, MS | 165 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Gulfport, MS | 141 |
| Gabapentin Other prescribers in Gulfport, MS | 141 |
| Letrozole Other prescribers in Gulfport, MS | 127 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Gulfport, MS | 100 |
| Oxycodone Hcl Other prescribers in Gulfport, MS | 89 |
| Potassium Chloride Other prescribers in Gulfport, MS | 79 |
| Mirtazapine Other prescribers in Gulfport, MS | 71 |
| Promethazine Hcl Other prescribers in Gulfport, MS | 70 |
| Buspirone Hcl Other prescribers in Gulfport, MS | 69 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 52 companies reported 299 payments worth $5,673 in total to this clinician.
| Pfizer Inc. | $390 |
|---|---|
| Novartis Pharmaceuticals Corporation | $379 |
| Merck Sharp & Dohme LLC | $317 |
| Daiichi Sankyo Inc. | $302 |
| Janssen Biotech, Inc. | $279 |
| Gilead Sciences, Inc. | $272 |
| Celgene Corporation | $232 |
| GlaxoSmithKline, LLC. | $223 |
| Food and Beverage | $5,649 |
|---|---|
| Education | $23.10 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP May 30, 2025 | Education in-kind Company’s descriptionJournal Article | $23.10 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.